Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Tubulointerstitial inflammation plays a critical role in the progression of diabetic nephropathy (DN), and nucleotide‐binding oligomerization domain‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasomes contribute to renal interstitial inflammation in DN. Decreased expression of optineurin (OPTN) is also associated with the progression of DN. We investigated the role of OPTN in activation of the NLRP3 inflammasome in DN. We initially examined the renal biopsy tissues of 172 patients with type 2 DN and 32 nondiabetic patients with renal hamartoma. Expression of renal OPTN was significantly lower in patients with DN and negatively correlated with urinary levels of IL‐1β and IL‐18. Confocal microscopy analysis of the biopsies indicated no NLRP3 or IL‐1β staining in OPTN‐positive renal tubular epithelial cells (RTECs), indicating a negative correlation of OPTN expression with the activation of NLRP3 inflammasome. In vitro studies of murine RTECs indicated the levels of OPTN mRNA and protein decreased significantly after stimulation by a high glucose (HG) treatment. Relative to RTECs given HG., RTECs overexpressing OPTN showed significantly lower levels of NLRP3 expression, cleavage of caspase‐1 and IL‐1β, and release of IL‐1β and IL‐18. Overexpression of OPTN in the presence of HG significantly increased the costaining of microtubule‐associated protein 1A/1B‐Iight chain 3‐II and translocase of outer mitochondrial membrane 20 in RTECs, suggesting that OPTN enhances mitophagy. In addition, mitochondrial division inhibitor 1 blocked the inhibitory effect of OPTN overexpression on the activation of NLRP3 inflammasome in the presence of HG., indicating that OPTN overexpression inhibited NLRP3 inflammasome activation by enhancement of mitophagy. OPTN gene silencing significantly enhanced production of mitochondrial reactive oxygen species (mtROS) in the presence of HG. Compared with HG+OPTN small interfering RNA (siRNA)‐treated RTECs, HG+OPTN siRNA+MitoTempo‐treated RTECs attenuated NLRP3 inflammasome activation, suggesting that OPTN gene silencing activates the NLRP3 inflammasome by increasing mtROS in HG‐treated RTECs. Taken together, our results demonstrate that OPTN inhibits the activation of NLRP3 inflammasome by enhancing mitophagy.—Chen, K., Feng, L., Hu, W., Chen, J., Wang, X., Wang, L., He, Y. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy. FASEB J. 33, 4571–4585 (2019). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Along similar lines, OPTN‐dependent activation of mitophagy improves signs of diabetic nephropathy by counteracting premature senescence (Chen et al, 2018b) and reducing NRLP3 inflammasome activation (Chen et al, 2019), hence supporting the hypothesis that autophagy may exert beneficial effects via the suppression of”
From Autophagy in major human diseases (2021) · cites this paper as Chen et al, 2019
In the citing paper
“hence supporting the hypothesis that autophagy may exert beneficial effects via the suppression of inflammatory reactions.”
From Autophagy in major human diseases (2021) · cites this paper as Chen et al, 2019
Citations
Cites
1 retracted
Mitochondrial DNA induces inflammation and increases TLR9/NF-κB expression in lung tissue
ZHANG, J.-Z., LIU, Z., LIU, J., REN, J.-X., & SUN, T.-S. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1650 · Cited by 194 · cited 1×
“In addition, mtROS can aggravate mitochondrial damage, resulting in the release of mitochondrial DNA, which can also activate the NF-ĸBpathwaybybinding toTLR9 (58).”
BackgroundRetractedA role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 1×
“Although the NLRP3 inflammasome responds to diverse signals, the generation of ROS appears to be critical for its activation (14, 15).”
BackgroundMechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774 · cited 2×
“Depolarization of themitochondrial membrane potential stabilizes ubiquitin phosphatase and tensin homolog-induced putative kinase 1 on the outer mitochondrial membrane, and this leads to recruitment of optineurin (OPTN) and mitophagosome formation (25).”
BackgroundNLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926 · cited 13×
“KEY WORDS: OPTN • tubulointerstitial inflammation • mitochondria • IL-1b • IL-18 Diabetic nephropathy (DN) is a common and serious complication of diabetes and a major cause of end-stage renal disease (1).”
BackgroundInfluentialMitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Kerr, J. S., Adriaanse, B. A., Greig, N. H., Mattson, M. P., Cader, M. Z., Bohr, V. A., & Fang, E. F. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.01.002 · Cited by 870
Limiting inflammation—the negative regulation of NF-κB and the NLRP3 inflammasome
Afonina, I. S., Zhong, Z., Karin, M., & Beyaert, R. (2017) · Nature Immunology · doi:10.1038/ni.3772 · Cited by 759 · cited 1×
“Research indicates that a 2-step process is responsible for activation of the NLRP3 inflammasome (12).”
BackgroundPark, J., Min, J.-S., Kim, B., Chae, U.-B., Yun, J. W., Choi, M.-S., Kong, I.-K., Chang, K.-T., & Lee, D.-S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.016 · Cited by 529
Cell Biology and Pathology of Podocytes
Greka, A., & Mundel, P. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153238 · Cited by 518
Han, Y., Xu, X., Tang, C., Gao, P., Chen, X., Xiong, X., Yang, M., Yang, S., Zhu, X., Yuan, S., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.013 · Cited by 458 · cited 1×
“A recent study reported that mtROS overproduction is associated with increases in NLRP3/IL-1b expression in the kidneys of patients with DN and in Lepr/Lepr mice (54).”
Background
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Mitochondrial control of inflammation
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00760-x · Cited by 1,027
Lin, Q., Li, S., Jiang, N., Shao, X., Zhang, M., Jin, H., Zhang, Z., Shen, J., Zhou, Y., Zhou, W., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101254 · Cited by 632
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Mitochondrial quality control in kidney injury and repair
Tang, C., Cai, J., Yin, X.-M., Weinberg, J. M., Venkatachalam, M. A., & Dong, Z. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00369-0 · Cited by 513
The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics
Panigrahi, D. P., Praharaj, P. P., Bhol, C. S., Mahapatra, K. K., Patra, S., Behera, B. P., Mishra, S. R., & Bhutia, S. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.015 · Cited by 362
Liu, X., Jiang, L., Li, Y., Huang, Y., Hu, X.-R., Zhu, W., Wang, X., Wu, Y., Meng, X., & Qi, X. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00721-5 · Cited by 163
Self-citationEmerging views of OPTN (optineurin) function in the autophagic process associated with disease
Qiu, Y., Wang, J., Li, H., Yang, B., Wang, J., He, Q., & Weng, Q. (2022) · Autophagy · doi:10.1080/15548627.2021.1908722 · Cited by 134
“Nephropathy DN OPTN mediated mitophagy [128,129]”
Fang, Q., Zheng, B., Liu, N., Liu, J., Liu, W., Huang, X., Zeng, X., Chen, L., Li, Z., & Ouyang, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.682482 · Cited by 122
“Furthermore, TMAO promotes the release of inflammatory factors by activating the NLRP3 inflammasome, thereby promoting vascular calcification, myocardial fibrosis, and vascular inflammation aggravating cardiovascular disease (Chen et al., 2017; Liu et al., 2019; Zhang et al., 2020).”
BackgroundNLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia–Reperfusion Injury
Wang, L., Ren, W., Wu, Q., Liu, T., Wei, Y. L., Ding, J., Zhou, C., Xu, H., & Yang, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.847440 · Cited by 123
Self-citationThe role of mitophagy in innate immune responses triggered by mitochondrial stress
Song, Y., Zhou, Y., & Zhou, X. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00659-x · Cited by 97
“Recently researches showed that OPTN inhibits the activation of NLRP3 inflammasome by enhancing mitophagy [150], and FUNDC1-mediated mitophagy sup-”
BackgroundZhu, Z., Hu, R., Li, J., Xing, X., Chen, J., Zhou, Q. X., & Sun, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107660 · Cited by 80
Self-citationBai, L., Li, J., Li, H., Song, J., Zhou, Y., Lu, R., Liu, B., Pang, Y., Zhang, P., Chen, J., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.08.021 · Cited by 74
Self-citationXu, J., Kitada, M., Ogura, Y., & Koya, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641852 · Cited by 79
“Resveratrol also attenuates EC inflammation by inducing autophagy in part via the activation of the AMPK/SIRT1 pathway (Chen et al., 2013) and SIRT1/FoxO1 pathway (Wu Q. et al., 2019).”
BackgroundMetabolic Changes and Oxidative Stress in Diabetic Kidney Disease
Sakashita, M., Tanaka, T., & Inagi, R. (2021) · Antioxidants · doi:10.3390/antiox10071143 · Cited by 80
“Conversely, increased expression of optineurin in glucose-loaded tubular cells ameliorates cellular senescence, accumulation of ROS, and activation of NLR family pyrin domain containing 3 (NLRP3) inflammasomes [21].”
BackgroundInvolvement of Inflammasome Components in Kidney Disease
Aranda‐Rivera, A. K., Srivastava, A., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., Mulay, S. R., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11020246 · Cited by 79
NLRP3-mediated pyroptosis in diabetic nephropathy
Wan, J., Liu, D., Pan, S., Zhou, S., & Liu, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.998574 · Cited by 74
Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets
Apostolova, N., Vezza, T., Muntane, J., Rocha, M., & Víctor, V. M. (2023) · Antioxidants & Redox Signaling · doi:10.1089/ars.2022.0016 · Cited by 58
“More specifically, a dearth of autophagy in renal cells, including TEC and podocytes, has been described in diabetic nephropathy.”
InfluentialGao, P., Yang, W., & Sun, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3120539 · Cited by 67
“, in which they showed that enhanced mitophagy could inhibit the NLRP3 inflammasome activation of renal tubular cells in DKD [154].”
BackgroundChen, J., He, J., Wang, X., Bai, L., Yang, X., Chen, J., He, Y., & Chen, K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123293 · Cited by 58
Self-citationMa, Z., Zhu, L., Wang, S., Guo, X., Sun, B., Wang, Q., & Chen, L. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2079525 · Cited by 56
Wang, Y., Sui, Z., Wang, M., & Liu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1196016 · Cited by 56
“In vivo, in vitro DKD patients Murine renal tubular epithelial cells Optineurin reduced mtROS and inhibited NLRP3 inflammasome (33)”
BackgroundLuo, Y., Long, M., Wu, X., & Zeng, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1703560 · Cited by 56
“Kehong Chen et al. discovered in DN renal tubular epithelial cells that the expression of optineurin (OPTN) was negatively correlated with NLRP3 in fl ammasome activation, which mediated renal interstitial in fl ammation (127).”
An integrated organoid omics map extends modeling potential of kidney disease
Lassé, M., Saghir, J. E., Berthier, C. C., Eddy, S. F., Fischer, M., Laufer, S. D., Kylies, D., Hutzfeldt, A. D., Bonin, L. L., Dumoulin, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39740-7 · Cited by 50
The Role of the Interplay Between Autophagy and NLRP3 Inflammasome in Metabolic Disorders
Lv, S., Wang, H., & Li, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634118 · Cited by 47
“The results of Chen et al. (2019) showed that the expression of optineurin (OPTN) was reduced and correlated negatively with NLRP3 inflammasome activation in patients with DN.”
BackgroundZhang, L., Jing, M., & Liu, Q. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119542 · Cited by 42
Liu, W., Liang, L., Zhang, Q., Li, Y., Yan, S., Tang, T., Ren, Y., Mo, J., Liu, F., Chen, X., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153650 · Cited by 38
Mitophagy in Diabetic Kidney Disease
Zhang, X., Feng, J., Li, X., Wu, D., Wang, Q., Li, S., & Shi, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.778011 · Cited by 40
Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
Shi, S., Zhang, B., Li, Y., Xu, X., Lv, J., Jia, Q., Chai, R., Xue, W., Li, Y., Wang, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.837270 · Cited by 46
“Furthermore, in the renal tubules of DKD mice, reduced expression of PINK1 and parkin in PTCs, decreased autophagosome formation, and optineurin overexpression enhancedmitophagy, thereby attenuating cellular senescence, mtROS accumulation, and NLRP3 inflammasome activation (116, 117).”
BackgroundChen, J., Lu, H., Wang, X., Yang, J., Luo, J., Wang, L., Yi, X., He, Y., & Chen, K. (2022) · The FASEB Journal · doi:10.1096/fj.202200496rr · Cited by 37
Self-citationChen, K., Chen, J., Wang, L., Yang, J., Xiao, F., Wang, X., Yuan, J., Wang, L., & He, Y. (2020) · The FASEB Journal · doi:10.1096/fj.202000053r · Cited by 39
Self-citationAutophagy and Mitophagy in Diabetic Kidney Disease—A Literature Review
Stăniguț, A. M., Tuta, L. A., Pana, C., Alexandrescu, L., Suceveanu, A. P., Blebea, N. M., & Văcăroiu, I. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020806 · Cited by 42
“On the opposite side, reduced expression of OPTN seems to be associated with the accumulation of affected mitochondria and activation of the NLRP3 inflammasome which leads to high release of IL-18 and IL-1 β and induces tubulointerstitial inflammation [135].”
Zhu, D., Zhong, J., Gong, X., & Wu, X. (2022) · APOPTOSIS · doi:10.1007/s10495-022-01794-1 · Cited by 31
“reported that optineurin-mediated mitophagy inhibited NLRP3 inflammasome activation in diabetic kidney disease [41].”
BackgroundYAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease
Ye, S., Zhang, M., Zheng, X., Li, S., Fan, Y., Wang, Y., Peng, H., Chen, S., Yang, J., Li, Y., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103435 · Cited by 40
“The current mainstream view is that mitophagy has a renoprotective effect on DKD, while hyperglycemic-induced inhibition of PINK1-Parkin signaling in tubule cells will lead to incompetent mitophagy/autophagy flux, resulting in inflammatory and senescence responses [8,13,58,59].”
Inflammasomes in cancer: Effect of epigenetic and autophagic modulations
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Bhol, C. S., Praharaj, P. P., Panigrahi, D. P., Patra, S., Singh, A., Patil, S., Dhiman, R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.013 · Cited by 31
Regulation of proteostasis and innate immunity via mitochondria-nuclear communication
Kim, S., Ramalho, T. R. D. O., & Haynes, C. M. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202310005 · Cited by 34
“Consistent with this finding, mitophagy limits inflammation by degrading damaged mitochondria in different pathologies including sepsis, nephropathy, and cancer (Zhong et al., 2016; Kim et al., 2016b; Chen et al., 2019; Li et al., 2019a, 2019b; Crespo et al., 2020).”
BackgroundZhou, Z., Ying, C., Zhou, X., Shi, Y., Xu, J., Zhu, Y., Wang, M., Li, Y., Li, X., & Xiang, J. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111934 · Cited by 30
Inokuchi, S., Yoshizumi, T., Toshima, T., Itoh, S., Yugawa, K., Harada, N., Mori, H., Fukuhara, T., Matsuura, Y., & Mori, M. (2021) · Cancer Medicine · doi:10.1002/cam4.3519 · Cited by 29
IL-17C Neutralization Protects the Kidney Against Acute Injury and Chronic Injury
Zhang, F., Yin, J., Liu, L., Liu, S., Zhang, G., Kong, Y., Wang, Y., Wang, N., Chen, X., & Wang, F. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2023.104607 · Cited by 30
Mitochondrial DNA on Tumor-Associated Macrophages Polarization and Immunity
Guo, Y., Tsai, H., Zhang, L., & Zhu, H. (2022) · Cancers · doi:10.3390/cancers14061452 · Cited by 27
Li, C., Pan, Y., Tan, Y., Wang, Y., & Sun, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.896014 · Cited by 34
“Evidence is accruing that the removal of mitochondria viamitophagy prevents apoptosis by reducing mitochondria-derived ROS and subsequent activation of the NLRP3 inflammasome (Chen et al., 2019; Lin et al., 2019).”
BackgroundMitophagy: A Novel Therapeutic Target for Treating DN
Yang, M., Li, C., Yang, S., Xiao, Y., Chen, W., Gao, P., Jiang, N., Xiong, S., Wei, L., Zhang, Q., et al. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666201006152656 · Cited by 27
Zhao, W., Zhou, L., Novák, P., Shi, X., Lin, C. B., Zhu, X., & Yin, K. (2022) · Journal of Diabetes Research · doi:10.1155/2022/2193768 · Cited by 32
“Expression of optineurin (an autophagic receptor for damaged mitochondria during mitochondrial phagocytosis) during the process of mitophagy was reduced in tubular epithelial cells from patients with DN compared with those from nondiabetic healthy individuals and was negatively correlated with renal interstitial infla…”
BackgroundImportant regulatory role of mitophagy in diabetic microvascular complications
Hu, X., Lv, J., Zhao, Y., Li, X., Qi, W., & Wang, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06307-7 · Cited by 25
“…the expression of OPTN was significantly reduced in renal biopsies of patients with type 2 DKD, and OPTN was found to suppress the activation of NLRP3 inflammasomes by enhancing mitophagy on HG-induced renal tubular epithelial cell (RTEC) model in mice thus playing a therapeutic role in DKD [124].”
Self-citationAdvances in understanding the innate immune‐associated diabetic kidney disease
Wan, S., Wan, S., Jiao, X., Cao, H., Gu, Y., Yan, L., Zheng, Y., Niu, P., & Shao, F. (2021) · The FASEB Journal · doi:10.1096/fj.202002334r · Cited by 24
Activation of the NLRC4 inflammasome in renal tubular epithelial cell injury in diabetic nephropathy
Wang, Y., Gou, R., Yu, L., Wang, L., Yang, Z., Guo, Y., & Tang, L. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10246 · Cited by 20
Self-citationDEK deficiency suppresses mitophagy to protect against house dust mite-induced asthma
Bai, Q., Liu, R., Quan, C., Han, X., Wang, D., Wang, C., Wang, Z., Li, L., Li, L., Piao, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1289774 · Cited by 27
“In diabetic nephropathy, Chen et al. (46) demonstrated that gene silencing of the autophagy receptor optineurin activated the NLRP3 in fl ammasome by increasing mtROS in renal tubular epithelial cells after stimulation with high glucose.”
BackgroundSu, L., Guo, P., Guo, X., He, Z., Zhao, Y., Zong, Y., Li, J., Chen, W., & Du, R. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60654-0 · Cited by 31
Liu, Z., Chen, Y., Niu, B., Yin, D., Feng, F., Gu, S., An, Q., Xu, J., An, N., Zhang, J., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.373 · Cited by 22
The Complex Interplay between Autophagy and NLRP3 Inflammasome in Renal Diseases
Ding, Y. J., Fu, X., Wang, Q., Liu, H., Wang, H., & Wu, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312766 · Cited by 20
“Collectively, optineurin improved DN by suppressing HG-induced NLRP3 inflammasome by promoting the mitophagy of RTECs [35].”
BackgroundPlowman, T. J., Shah, M. H., Fernandez, E., Christensen, H., Aiges, M., & Ramana, K. V. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666220922114701 · Cited by 22
Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases
Makarov, M., & Korkotian, E. (2023) · Toxins · doi:10.3390/toxins15030202 · Cited by 20
Liu, T., Jin, Q., Yang, L., Mao, H., Ma, F., Wang, Y., Li, P., & Zhan, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1142276 · Cited by 21
Wang, Y., Wang, Q., Wang, M., Wang, X., Liu, Q., Lv, S., Nie, H., & Liu, G. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4617 · Cited by 13
Self-citationLiu, T., Jin, Q., Ren, F., Yang, L., Mao, H., Ma, F., Wang, Y., Li, P., & Zhan, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113670 · Cited by 13
Endoplasmic reticulum-mitochondria crosstalk: new mechanisms in the development of atherosclerosis
Li, M., Xiao, Y., Dai, L., Chen, S., Pei, W., & Tan, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1573499 · Cited by 24
Wang, F., Xu, L. Z., Dong, G., Zhu, M., Liu, L., & Wang, B. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.109 · Cited by 10
Jiang, H., Xie, Y., Hu, Z., Lu, J., Zhang, J., Li, H., Zeng, K., Peng, W., Yang, C., Huang, J., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3002961 · Cited by 9
Zhang, Z., Bi, Y., Zhou, F., Zhang, D., Xu, S., Zhang, X., Fan, Z.-H., Yao, Z., & He, Y. (2024) · Journal of Diabetes Research · doi:10.1155/2024/8772009 · Cited by 10
“What is more, the NLRP3 in fl ammasome can be activated in renal tubules of diabetic patients with tubulointerstitial injury and glomerular endothelial cells and in podocytes of mice with DKD [26, 27].”
BackgroundSelf-citationSun, Y., Pan, G., Wang, C., & Xiao, Z. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2538798 · Cited by 9
“By enhancing mitophagy, overexpression of the optineurin gene can inhibit the activation of the NLrP3 inflammasome [127] . in addition, a recent study revealed that the suppression of toll-like receptor 9 gene expression in diabetic nephropathy mice can also effectively inhibit the activation of…”
Inflammasomes Are Influenced by Epigenetic and Autophagy Mechanisms in Colorectal Cancer Signaling
Műzes, G., & Sípos, F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116167 · Cited by 9
“Optineurin exerts a direct inhibitory effect on NLRP3 [96].”
BackgroundLi, X., Yu, X., Yu, F., Fu, C., Zhao, W., Liu, X., Dai, C., Gao, H., Cheng, M., & Li, B. (2024) · Phytotherapy Research · doi:10.1002/ptr.8134 · Cited by 11
“OPTN inhibited the activation of NOD-like receptor thermal protein domain-associated protein 3 inflammasomes and reduced the level of mitochondrial reactive oxygen species in diabetic nephropathy (Chen et al., 2019).”
BackgroundWang, Y., Song, D., & Tang, L. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s402290 · Cited by 8
“One study found that under high glucose conditions, overexpression of OPTN increased the co-staining of LC3II and OMM 20 translocase in mice RTECs cultured in vitro, while enhancing mitophagy, and significantly reducing the expression of NLRP3, the cleavage levels of caspase-1 and IL-1β, and the releases of IL-1β and…”
BackgroundInfluentialAxitinib attenuates the progression of liver fibrosis by restoring mitochondrial function
Li, H., Zhang, R., Hu, Y., Li, J., Yang, Y., Wu, D., Gu, X., Zhang, F., Zhou, H., & Yang, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110555 · Cited by 8
Selective autophagy in kidney health and disease
Fu, Y. W., Livingston, M. J., Dong, G., Chen, A., Cai, J., & Dong, Z. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01082-0 · Cited by 9
“Decreased OPTN expression has also been observed in renal tubular epithelial cells from patients with DKD, whereas podocyte PGRN levels were reduced in human biopsy samples showing diabetic nephropathy 64,65 .”
Yu, Q., Mao, H., Vijayalakshmi, A., & Zhou, M. (2025) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2753 · Cited by 4
Li, X., Yu, F., Fu, C., Yu, X., Xu, M., & Cheng, M. (2021) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202100019 · Cited by 4
“A large number of studies have shown that OPTN inhibits the activation of nucleotide-binding oligomerization domain like receptor family pyrin domain-containing 3 (NLRP3) inflammasome by enhancingmitophagy in diabetic nephropathy [29].”
BackgroundLiu, J., Feng, L., Jia, Q., Meng, J., Zhao, Y., Ren, L., Yan, Z., Wang, M., & Qin, J. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2311344 · Cited by 4
“Consistent findings have been noted in renal biopsy samples from DKD patients (Yao et al., 2022; Chen et al., 2019).”
Self-citationLuo, J., Lu, F., Cuciureanu, M. D., Xu, X., Dong, H., & Gong, M. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2620218 · Cited by 4
“…proteins [124]. in contrast, overexpression of oPtN in DKD kidneys inhibits NLrP3 inflammasome activation by promoting mitophagy in renal tubules [125]. finally, high glucose-induced tXNiP expression disrupts tubular autophagy and mitophagy, which is mediated by the activation of the mtor…”
TSPO-mediated mitochondrial retrograde signaling primes the microglial NLRP3 inflammasome
Singh, A., Rigon, M., Guo, T., Faccenda, D., Lakshmanan, G., Xia, D., Caldeira, M. G., Tremoleda, J. L., Al-Khateeb, Z. F., Abeti, R., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108145 · Cited by 7
“However, excessive mitophagy can also deplete the mitochondrial pool necessary for innate immune signalling [60,61].”
Li, X., Liu, S., Huangfu, J., Lai, N., & Shang, Y. (2024) · Journal of Medical Biochemistry · doi:10.5937/jomb0-45950 · Cited by 2
“In recent years, more and more studies have shown that the inflammatory response is an important factor in developing diabetic kidney disease (20) and that renal decompensation in diabetic patients is closely related to diabetes-induced renal interstitial inflammation (21).”
BackgroundThe dual role of mitophagy in cancer and its targeting for effective anticancer therapy
Mishra, S. R., Mishra, P., Dhiman, R., & Bhutia, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15260-3.00002-8 · Cited by 2
[Research Progress in Stress-Induced Senescence of Renal Tubular Cells in Diabetic Nephropathy].
Yi, X., He, Y., & Chen, K. (2023) · PubMed Central · doi:10.12182/20231160107 · Cited by 1
Self-citationKelly, S. S., Sarkar, S., Williams, S. M., Fu, A., Butterworth, E. A., Sagendorf, T. J., Nierves, L. A., Kwon, Y. M., Li, X., Petyuk, V., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.10.687674 · Cited by 2
“Similarly, OPTN-mediated autophagy helps restrain pyroptosis by inhibiting inflammasome activation 43 .”
Self-citationProgress in the correlation of mitochondrial dysfunction and diabetic kidney disease
Shu-yan, Z. (2022) · International Journal of Frontiers in Medicine · doi:10.25236/ijfm.2022.040410
Shamla, H. E., Ali, D. A., Khodeir, S. A., & El-Serogy, H. A. (2023) · International Journal of Clinical and Diagnostic Pathology · doi:10.33545/pathol.2023.v6.i3a.526
Mitochondria drive microglial NRLP3 inflammasome activation via TSPOPreprint
Singh, A., Rigon, M., Caldeira, M. G., Faccenda, D., Xia, D., Lopez-Tremoleda, J., Al-Khateeb, Z. F. H., Guo, T., Abeti, R., Giunti, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.18.585507
“Previously it was also postulated that mitophagy coincides with a decrease in several inflammatory molecules, meaning that mitophagy regulation dictates the degree of inflammation and vice versa [22, 49-51].”
BackgroundMitochondrial transfer: A novel mechanism and promising therapeutic strategy in ageing kidney
Xu, J., Li, X., Zhang, Z., Wu, J., Yu, H., Wu, Y. C., Wang, D., Bao, R., Wang, T., Zhang, Y., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103051
Fonctions mitochondriales de la protéine Optineurine : neurodégénérescence et cancer
D’Urso, B. (2025) · theses.fr (ABES) · doi:10.70675/fe933860ze386z4ca5zaa6fzfcd35c62ce81
Wei, Y., Zhang, S., Yu, X., Tan, Y., Zha, M., & Yu, J. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122194 · Cited by 1
Tubular injury in diabetic kidney disease: a focus on regulated cell death
Sun, H., Chen, W., Huang, H., Chen, L., He, S., Wang, X., & Xie, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1877238
Self-citationYuan, F., Cao, X., Xue, F., Yao, F., Dong, Z., Zhang, B., & Sun, X. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.08.006
Gong, Y., Liu, Q., Dai, H., Li, J., 常秀林, & Zhang, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198758
“…is an inflammatory form of cell death mediated by inflammasome activation and caspase-1/11, characterized by gasdermin D (GSDMD) cleavage-induced plasma membrane pore formation and the release of pro-inflammatory cytokines, including interleukin-1 β (IL-1 β ) and interleukin-18 (IL-18) [44].”
Unraveling the pyroptosis-mitophagy axis: from molecular mechanisms to therapeutic opportunities
Ban, J., 陈然兴, Ao, L., Zhao, H., Li, J., Wei, Y., & Huang, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1950578
“In summary, the mitophagy-pyroptosis axis operates as an integrated bistable switch, wherein mitophagy inhibits pyroptosis through mitochondrial quality control (79, 83, 114, 115), while pyroptosis, in turn, obstructs mitophagy via caspase-1-mediated PINK1/Parkin degradation (112, 124).”
Metadata
- Authors
- Chen, K., Feng, L., Hu, W., Chen, J., Wang, X., Wang, L., & He, Y.
- Affiliations
- Army Medical University (CN)
- Corresponding author
- He, Yani
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2018-12-20
- Volume
- 33
- Issue
- 3
- Pages
- 4571-4585
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2906664454
- Cited by
- 85
- References
- 58
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 13 · 2023: 11 · 2022: 15 · 2021: 17 · 2020: 8 · 2019: 3
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81770731, 81670661)
- National Science and Technology Planning Project (2015BAI12B06)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- optineurin, NLRP3 inflammasome, mitophagy, diabetic nephropathy, renal tubular epithelial cells, tubulointerstitial inflammation, mitochondrial reactive oxygen species, high glucose, IL-1β, IL-18, caspase-1, type 2 diabetes, renal hamartoma
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Adult, Aged, Animals, Cells, Cultured, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Epithelial Cells, Female, Glucose, Humans, Kidney Tubules, Proximal, Male, Mice, Inbred C57BL, Middle Aged, Mitochondria, Recombinant Proteins, RNA, Messenger, Reactive Oxygen Species, Microscopy, Confocal, Cell Cycle Proteins, Membrane Transport Proteins, Mice, Membrane Potential, Mitochondrial, Inflammasomes, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.